It refers to a notable 2015 paper in Physical Review D titled "Self-similar inverse cascade of magnetic helicity driven by the chiral anomaly" (Phys. Rev. D 92, 125031 ). This research explores how magnetic fields behave in chiral plasmas, which is relevant to understanding the early universe.
It is associated with stratigraphic and geothermal studies in Pakistan, often appearing in technical datasets related to lithology prediction and energy production. Digital & Social Contexts 125031
Recent supplemental applications (e.g., BLA 125031/S-0202) have added critical safety information to the drug's labeling, including increased risks of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) when used alongside chemotherapy or radiation for breast and lung cancer. Scientific Literature Identifier It refers to a notable 2015 paper in
Neulasta is a leukocyte growth factor used to decrease the incidence of infection—manifested by febrile neutropenia—in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. This research explores how magnetic fields behave in
In technical troubleshooting, it appears as a timestamp or unique ID in system logs for home automation platforms like Homey Pro , specifically within the Audit app used for debugging.
In the medical field, is the Biologics License Application (BLA) number assigned by the FDA to Neulasta (pegfilgrastim) .
The number also serves as a specific article identifier in high-level physics and engineering research: